NetraMind Innovations
About NetraMind Innovations
NetraMind Innovations is a healthcare AI company specializing in ophthalmology. They leverage cutting-edge technologies and advanced analytics to revolutionize eye care and enhance patient outcomes. Their core offering is a comprehensive, AI-powered multimodal ophthalmic screening and analytics platform that transforms routine eye scans into actionable insights for both clinical workflows and research environments.
For physicians, NetraMind’s platform provides AI-driven tools to assist in the diagnosis and prediction of eye disease progression, enabling more optimal treatment decisions. The platform excels at managing diverse medical data, including images, patient records, and diagnostic reports, ensuring efficient storage, retrieval, and organization. Their expertise in multimodal image registration allows for seamless integration and alignment of images from different sources, facilitating accurate comparisons and comprehensive analysis. Utilizing advanced AI algorithms, NetraMind develops predictive models to forecast disease progression, treatment outcomes, and risk factors, empowering clinicians with valuable decision-making tools. They also specialize in personalized healthcare solutions, offering tailored analysis and treatment recommendations based on individual patient characteristics, medical history, and diagnostic findings. Their solutions are particularly tailored for leading causes of blindness such as age-related macular degeneration (AMD) and diabetic retinopathy (DR), as well as other conditions like Myopia, Retinal Vein Occlusion (RVO), and Central Serous Chorioretinopathy (CSCR).
Focus Areas
Business Intelligence
| Key Investors | LifeX Ventures, R.K. Mellon Social Impact Investment, Shear Family Foundation, Henry L. Hillman Foundation, Richard King Mellon Foundation |
| Partnerships | Heidelberg Engineering, University of Pittsburgh Innovation Institute, LifeX |
| Technology | AI-powered multimodal ophthalmic screening and analytics platform, cloud-native (implied by AppWay integration and data management), AI operating system (Skopix) |
What Physicians Need to Know
NetraMind Innovations provides AI-driven cross-platform solutions that are both clinical and research-focused, aiming for cost-effectiveness. Their AI-assisted quantification offers automated segmentation of retinal/choroidal layers and detection of biomarkers, reducing inter-grader variability and speeding up analysis. The NMI-ChoroidAI application provides objective, reproducible, and fully automated choroid analyses in a fraction of the time compared to manual segmentation, enhancing diagnostic confidence and streamlining workflow. The platform supports multimodal imaging (OCT, fundus, FAF, OCTA) and offers exportable structured data for statistical analysis, fitting into existing research pipelines. Their AI-powered annotation tool improves labeling quality, enables consistent segmentation, and supports streamlined case management across various imaging modalities. NetraMind's predictive models forecast disease progression, treatment outcomes, and risk factors, empowering clinicians with valuable decision-making tools and supporting personalized healthcare solutions.
NetraMind Innovations' NMI-ChoroidAI and NMI Outer Retinal Analyser (ORA) applications are available on the Heidelberg AppWay marketplace, enabling seamless integration into clinical workflows and research protocols for users of Heidelberg Engineering's SPECTRALISu00ae OCT.
Reviews & Opinions
Videos
News, demos, and interviews about NetraMind Innovations.
Videos load interactively. If none appear, search YouTube for NetraMind Innovations →
Press & Coverage
Frequently Asked Questions
Related Companies
CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]
MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]
allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]